The Oil & Gas Journal, first published in 1902, is the world's most widely read petroleum industry publication. OGJ delivers international oil and gas industry news; analysis of issues and events; practical technology for design, operation, and maintenance of oil and gas operations; and important statistics on energy markets and industry activity.

OGJ is edited to meet the needs of engineers, geoscientists, managers, and executives throughout the oil and gas industry. It is part of Endeavor Business Media, Nashville, Tenn., which also publishes Offshore Magazine.

Endeavor Business Media’s Petroleum Group also produces targeted e-Newsletters; hosts global conferences and exhibitions, seminars, and forums; and publishes directories, technical books, print and electronic databases, surveys, and maps.

Additional Information

Website & Technical Help

For help with subscription purchases or refunds, or trouble logging into the paid subscription content on www.ogj.com, please contact Customer Service at [email protected] or call 1-847-559-7598.

For more customer service information, please click here.

ADAP Advocacy Airs Commercial to Open National Advocacy Campaign Calling for Reforming the 340B Drug Pricing Program





Commercial: Is the 340B Drug Pricing Program the Next 'Too Big to Fail'?

WASHINGTON, DC, May 15, 2025 /24-7PressRelease/ -- ADAP Advocacy today, as part of its 340B Project, aired a new commercial calling for reforms to the 340B Drug Pricing Program. The commercial opens a national advocacy campaign, asking a critical question: "Is the 340B Drug Pricing Program the Next 'Too Big to Fail'?".

Brandon M. Macsata, CEO of ADAP Advocacy, summarized: "We're sounding the alarm on why common-sense reforms are needed to ensure the integrity of the nation's second largest federally sponsored drug program, behind only Medicare Part D. The '340B Too Big To Fail' national advocacy campaign builds on the work being done by our 340B Patient Advisory Committee. It is grounded in the premise that the 340B Program's lack of meaningful accountability or transparency standards, especially among the big hospital systems, despite explosive growth, draws parallels to the collapse of the financial markets in 2007-08 after years of minimal federal oversight of the big investment banks."

The commercial will air in the greater metropolitan DC market while Congress is in session. The '340B Too Big To Fail' national advocacy campaign will run through the end of the year, highlighting hospitals' declining charity, rising healthcare executive compensation, and exploding patient medical debt, among some other issues.

The commercial is available online at https://youtu.be/IIr9QWaQaMA.

To learn more about ADAP Advocacy, 340B Drug Pricing Program, or the new 340B commercial, please email info@adapadvocacy.org.

About ADAP Advocacy: ADAP Advocacy's mission is to promote and enhance the AIDS Drug Assistance Programs (ADAPs) and improve access to care for persons living with HIV/AIDS. ADAP Advocacy works with advocates, community, health care, government, patients, pharmaceutical companies, and other stakeholders to raise awareness, offer patient educational programs, and foster greater community collaboration.

---
Press release service and press release distribution provided by https://www.24-7pressrelease.com
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.